Autologous bone marrow transplantation in the treatment of cutaneous lymphoma;AUTOGREFFE DE MOELLE OSSEUSE DANS LE TRAITEMENT DES LYMPHOMES CUTANES

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 2, 1996, Pages 79-84

  Zeitoun, C ^a   Baccard, M ^a   Marolleau, J P ^a   Rybojad, M ^a   Baruchel, A ^a   Morel, P ^a   Brice, P ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; SCHOOL CHILD; SKIN LYMPHOMA;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; SKIN NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 0029942302     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Joly P, Charlotte F, Leibowitch M, et al. Cutaneous lymphomas other than mycosis fongoides: follow-up study of 52 patients. J Clin Oncol 1991;9:1994-2001.
2. Joly P, Thomine E, Lauret P. Cutaneous lymphomas other than mycosis fungoides. Semin Dermatol 1994;13:172-9.
3. Abel EA, Wood GS, Hoppe RT. Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment. CA Cancer J Clin 1993;43:93-115.
4. Philip T, Guglielmi C, Chauvin F, et al. Autologous bone marrow transplantation versus conventional chemotherapy in relapsed non Hodgkin lymphoma: final analysis of the PARMA randomized study (216 patients). Proc ASCO 1995;14:390.
5. Bigler RD, Crilley P, Micaily B, et al. Autologous bone marrow transplantation for advanced stage mycosis fungoides. Bone Marrow Transplant 1991;7:133-7.
6. Moreau P, Le Tortorec S, Mahé MA, et al. Autologous bone marrow transplantation using TBI and CBV for disseminated high/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma. Bone Marrow Transplant 1994;14:775-8.
7. Thomas ED, Storb R. Technique for human marrow grafting. Blood 1970;36:507-515.
8. Beaujean F, Flesch M, Ganem G, Hervé P, Kuentz M, Pulik M. L'hématologie de Bernard Dreyfus. Flammarion Médecine-Sciences, 1992:1399-420.
9. Ganem G, Cosset JM, Le Bourgeois JP. Irradiation corporelle totale dans le conditionnement des greffes de moelle osseuse. Ann Med Interne 1989;140:387-92.
10. Brice P, Divine M, Marolleau JP, et al. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Bone Marrow Transplant 1994;14:51-5.
11. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 1989;2:580-5.
12. Freedman AS, Takvorian T, Anderson KC, et al. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 1990;8:784-91.
13. Kessinger A, Vose JM, Bierman PJ, Armitage JO. High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging. Exp Hematol 1991;19: 1013-6.
14. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies (Editorial). Blood 1991;77:211-3.
15. Appelbaum FR, Thomas ED. Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma. J Clin Oncol 1983;1:440-7.
16. Takvorian T, Canellos GP, Ritz J, et al. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 1987;316:1499-505.
17. Bosly A, Coiffier B, Gisselbrecht C, et al. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J Clin Oncol 1992;10: 1615-23.
18. Haouin C, Lepage E, Gisselbrecht C, et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 454 patients. J Clin Oncology 1994;12:2543-51.
19. Rohatiner AZS, Johnson PWM, Price CGA, et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994;12:1177-84.
20. Colombat P, Donadio D, Fouillard L et al. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994;13:157-62.
21. Koeppel MC, Stoppa AM, Resbeut M, Blaise D, Coignet M, Coulier L, et al. Mycosis fungoides and allogenic bone marrow transplantation. Acta Derm Venereol (Stockh) 1994;74:331-2.
22. Freedman AS, Takvorian T, Neuberg D, et al. Autologous bone-marrow transplantation in poor prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. J Clin Oncol 1993;11:931-6.